Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL809377 | 0.78 | CA1 (0.38) | MEN1KMT2ACA1CA2CA9 | |
| SCHEMBL20198131 | 0.75 | MEN1 (0.38) | MEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL6548087 | 0.74 | CA1 (0.36) | MEN1KMT2ACA1CA2CA9 | |
| SCHEMBL20980042 | 0.72 | CA1 (0.35) | MEN1KMT2ACA1CA2CA9 | |
| SCHEMBL3013709 | 0.71 | MEN1 (0.46) | MEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL4596209 | 0.69 | MEN1 (0.50) | MEN1KMT2ACA1CA2CA9 | |
| SCHEMBL8574969 | 0.67 | MEN1 (0.42) | MEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL19214403 | 0.67 | CA1 (0.32) | CA1CA2CA9 | |
| SCHEMBL108836 | 0.67 | CA1 (0.32) | CA1CA2CA9 | |
| SCHEMBL30956645 | 0.67 | MEN1 (0.35) | MEN1KMT2ACA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1583727-B1 | PROCESS FOR RECOVERY OF 1,1,1,3,3,3-HEXAFLUOROISOPROPANOL FROM THE WASTE STREAM OF SEVOFLURANE SYNTHESIS | BAXTER INT INC (A DELAWARE CORPORATION) (US) | 2017-03-15 | — | — | EP | claimed |
| EP-1583727-B1 | PROCESS FOR RECOVERY OF 1,1,1,3,3,3-HEXAFLUOROISOPROPANOL FROM THE WASTE STREAM OF SEVOFLURANE SYNTHESIS | BAXTER INT INC (A DELAWARE CORPORATION) (US) | 2017-03-15 | — | — | EP | disclosed |
| US-7375254-B2 | Process for recovery of 1,1,1,3,3,3-hexafluoroisopropanol from the waste stream of sevoflurane synthesis | BAXTER INTERNATIONAL INC. (US) | 2008-05-20 | — | — | US | disclosed |
| US-7375254-B2 | Process for recovery of 1,1,1,3,3,3-hexafluoroisopropanol from the waste stream of sevoflurane synthesis | BAXTER INTERNATIONAL INC. (US) | 2008-05-20 | — | — | US | disclosed |
| US-6987204-B2 | Process for recovery of 1,1,1,3,3,3-hexafluoroisopropanol from the waste stream of sevoflurane synthesis | BAXTER INTERNATIONAL INC. (US) | 2006-01-17 | — | — | US | disclosed |
| EP-1583727-A1 | PROCESS FOR RECOVERY OF 1,1,1,3,3,3-HEXAFLUOROISOPROPANOL FROM THE WASTE STREAM OF SEVOFLURANE SYNTHESIS | BAXTER INTERNATIONAL INC. (a Delaware corporation) (US) | 2005-10-12 | — | — | EP | disclosed |
| US-20050222468-A1 | Process for recovery of 1,1,1,3,3,3-hexafluoroisopropanol from the waste stream of sevoflurane synthesis | BAXTER INTERNATIONAL INC. | 2005-10-06 | — | — | US | disclosed |
| WO-2004065340-A1 | PROCESS FOR RECOVERY OF 1,1,1,3,3,3-HEXAFLUOROISOPROPANOL FROM THE WASTE STREAM OF SEVOFLURANE SYNTHESIS | BAXTER INTERNATIONAL INC. (US) | 2004-08-05 | — | — | WO | disclosed |
| US-20040147779-A1 | Process for recovery of 1,1,1,3,3,3-hexafluoroisopropanol from the waste stream of sevoflurane synthesis | BAXTER INTERNATIONAL INC | 2004-07-29 | — | — | US | disclosed |
| EP-0830436-A1 | REFRIGERANTS BASED ON HYDROFLUOROETHER OF FLUOROETHER | E.I. DU PONT DE NEMOURS & CO. (INC.) (US) | 1998-03-25 | — | — | EP | disclosed |
| WO-1996040834-A1 | REFRIGERANTS BASED ON HYDROFLUOROETHER OF FLUOROETHER | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050222468-A1 | Process for recovery of 1,1,1,3,3,3-hexafluoroisopropanol from the waste stream of sevoflurane synthesis | PFDN2, HIRIP3, PFDN1 | MEN1 4323/4885KMT2A 2207/4885ALDH1A1 2777/4885 |
| US-20040147779-A1 | Process for recovery of 1,1,1,3,3,3-hexafluoroisopropanol from the waste stream of sevoflurane synthesis | PFDN2, HAO2, PUM2 | MEN1 4648/4885KMT2A 2251/4885ALDH1A1 3093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.